Wednesday, November 22, 2017 8:56:56 AM
So PAOG will not be selling the MJ they will be providing the facilities, it would be no different that a doctors office leasing out space for a pharmacy to process perscriptions. Though they may have a business relationship the businesses are completely seperate and not in violation of the law.
Can't you see the difference and how smart PAOG is being by generating revenues by leasing out office space while at the same time making their locations more desirable by offering those additional beneifts and services?
Additionally, the news yesterday further illustrates how much of a legtimate business they are building, why hold a free demonstration on the use of Narcan which really has nothing to do with their business per se except building a relationship in the community as an active medical facility that is battling the opiod epidemic. Why would a "scam" "share selling scheme" hold such a clinic for free that has nothing to do with their operations that is more of a charitable service for the state of Ohio. Just furter solidifies them as a legit medical clinic fighting the current epidemic.
Further the PR sets the stage for further PR's related to the execution of the LIO's, the scheduling of the Narcan demonstration and opening of additional clinics. I would bet this will all coincide with the increased demand for MJ stocks as we head into December and January.
The company has plenty of things to announce going forward and already has clinics opened, is generating increasing revenues quarter over quarter and a very decent share structure with minimal dilution for a growing pink sheet stock.
Frankly the only thing people can point to is that the price declined from the most recent high which is normal for all stocks including big board. The key is that this time it held a higher low than the previous retrace that went to .003 this time is held support in the .006's more than double the previous dip.
There is plenty to look forward to and plenty to be excited about over the next couple months and there are plenty of people watching and wanting to get in before the rush
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM